slides · global inventory
Turn
Beat collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 37,461
Current window 22,171-22,200
Pages 1,249
Rows per page 30
Beat
22,171-22,200 of 37,461
17
The slide uses a waterfall-style bridge to explain the growth in deposits, categorized by stability and beta.Regions Financial Corporation | Results Presentation Deck | 38 slides · Regions
Conference presentation Investor relations Beat · SatisfactionLoop · Zoom In1 hit
18
The slide uses a combination of a line chart for historical delinquency trends and a bar chart for deposit balance growth.Regions Financial Corporation | Results Presentation Deck | 38 slides · Regions
Conference presentation Investor relations Beat · SatisfactionLoop · Zoom In1 hit
19
Includes annotations for 'Stimulus Round 1' and 'Stimulus Round 2' on the consumer chart.Regions Financial Corporation | Results Presentation Deck | 38 slides · Regions
Conference presentation Investor relations Beat · SatisfactionLoop · Zoom In1 hit
20
Includes a chart showing NIM range projections against Fed Funds rate scenarios.Regions Financial Corporation | Results Presentation Deck | 38 slides · Regions
Conference presentation Investor relations Beat · SatisfactionLoop · Zoom In1 hit
21
The chart illustrates a 15-17% CAGR expectation for NII growth.Regions Financial Corporation | Results Presentation Deck | 38 slides · Regions
Conference presentation Investor relations Beat · SatisfactionLoop · Zoom In1 hit
04
The diagram shows the signaling pathway from extracellular receptor binding to nuclear cytokine induction.Revelation Biosciences | Investor Presentation Deck | 18 slides · Revelation Biosciences
Pitch deck Investor relations Beat · SolutionLoop · Golden Circle1 hit
05
Revelation Biosciences | Investor Presentation Deck | 18 slidesRevelation Biosciences | Investor Presentation Deck | 18 slides · Revelation Biosciences
Pitch deck Investor relations Beat · SolutionLoop · Golden Circle1 hit
06
Includes a medical illustration of IV administration and clinical mechanism.Revelation Biosciences | Investor Presentation Deck | 18 slides · Revelation Biosciences
Pitch deck Investor relations Beat · SolutionLoop · Golden Circle1 hit
07
The slide presents three dot plots comparing Vehicle, MPLA, PHAD, 3D PHAD, and 3D 6-Acyl PHAD treatments.Revelation Biosciences | Investor Presentation Deck | 18 slides · Revelation Biosciences
Pitch deck Investor relations Beat · SolutionLoop · Zoom In1 hit
08
Includes three dot plots for bacterial clearance (Lung, Spleen, Kidney) and one Kaplan-Meier survival curve.Revelation Biosciences | Investor Presentation Deck | 18 slides · Revelation Biosciences
Pitch deck Investor relations Beat · SolutionLoop · Zoom In1 hit
09
Revelation Biosciences | Investor Presentation Deck | 18 slidesRevelation Biosciences | Investor Presentation Deck | 18 slides · Revelation Biosciences
Pitch deck Investor relations Beat · SolutionLoop · Golden Circle1 hit
10
Includes a before-after comparison of medical efficacy and a market growth chart.Revelation Biosciences | Investor Presentation Deck | 18 slides · Revelation Biosciences
Pitch deck Investor relations Beat · SolutionLoop · Golden Circle1 hit
11
The slide uses a combination of line charts and bar charts to present clinical trial results.Revelation Biosciences | Investor Presentation Deck | 18 slides · Revelation Biosciences
Pitch deck Investor relations Beat · SolutionLoop · Golden Circle1 hit
12
Revelation Biosciences | Investor Presentation Deck | 18 slidesRevelation Biosciences | Investor Presentation Deck | 18 slides · Revelation Biosciences
Pitch deck Investor relations Beat · SolutionLoop · Golden Circle1 hit
13
Includes a biological pathway diagram illustrating the mechanism of action of PHAD on TLR4 pathways.Revelation Biosciences | Investor Presentation Deck | 18 slides · Revelation Biosciences
Pitch deck Investor relations Beat · SolutionLoop · Golden Circle1 hit
14
Revelation Biosciences | Investor Presentation Deck | 18 slidesRevelation Biosciences | Investor Presentation Deck | 18 slides · Revelation Biosciences
Pitch deck Investor relations Beat · SolutionLoop · Golden Circle1 hit
15
Includes a small sketch of the test device with a 3-inch scale reference.Revelation Biosciences | Investor Presentation Deck | 18 slides · Revelation Biosciences
Pitch deck Investor relations Beat · SolutionLoop · Golden Circle1 hit
13
Silicon Valley Bank | Results Presentation Deck | 52 slidesSilicon Valley Bank | Results Presentation Deck | 52 slides · SVB
Conference presentation Investor relations Beat · Solution & Approach1 hit
14
The chart uses a dual-axis approach to overlay GDP share percentages on top of investment and formation volume trends.Silicon Valley Bank | Results Presentation Deck | 52 slides · SVB
Conference presentation Investor relations Beat · Solution & Approach1 hit
15
The chart uses a combination of stacked bars for absolute values and line graphs for growth percentages, with shaded regions highlighting historical market events.Silicon Valley Bank | Results Presentation Deck | 52 slides · SVB
Conference presentation Investor relations Beat · Solution & Approach1 hit
16
Slide from SVB Q3 2022 Financial Highlights deck.Silicon Valley Bank | Results Presentation Deck | 52 slides · SVB
Conference presentation Investor relations Beat · Solution & Approach1 hit
17
The slide uses a color-coded bar at the bottom to represent the portfolio composition.Silicon Valley Bank | Results Presentation Deck | 52 slides · SVB
Conference presentation Investor relations Beat · Solution & Approach1 hit
18
The slide highlights tenure and historical credit performance to build investor confidence.Silicon Valley Bank | Results Presentation Deck | 52 slides · SVB
Conference presentation Investor relations Beat · Solution & Approach1 hit
19
The slide highlights a target Tier 1 leverage ratio of 7-8%.Silicon Valley Bank | Results Presentation Deck | 52 slides · SVB
Conference presentation Investor relations Beat · Solution & Approach1 hit
20
The slide uses a four-column layout with icons for each strategic pillar.Silicon Valley Bank | Results Presentation Deck | 52 slides · SVB
Conference presentation Investor relations Beat · Solution & Approach1 hit
09
The slide outlines the market opportunity, technology, and specific applications for the SP-26 program.Silo Pharma | Investor Presentation Deck | 24 slides · Silo Pharma
Pitch deck Investor relations Beat · Solution1 hit
10
Slide 10 of a pitch deck for Silo Pharma.Silo Pharma | Investor Presentation Deck | 24 slides · Silo Pharma
Pitch deck Investor relations Beat · Solution1 hit
11
The slide outlines a specific asset (SPU-21) under a license agreement with UMB, detailing market size, technical mechanism, and research status.Silo Pharma | Investor Presentation Deck | 24 slides · Silo Pharma
Pitch deck Investor relations Beat · Solution1 hit
12
Slide 12 of a pitch deck.Silo Pharma | Investor Presentation Deck | 24 slides · Silo Pharma
Pitch deck Investor relations Beat · SolutionLoop · Voice Of Customer1 hit
13
The slide outlines a specific pharmaceutical asset (SPC-15) and its market context.Silo Pharma | Investor Presentation Deck | 24 slides · Silo Pharma
Pitch deck Investor relations Beat · SolutionLoop · Voice Of Customer1 hit